|Articles|February 9, 2004
Deciphering between biologic psoriasis treatments
February 10 -- Craig L. Leonardi, M.D., spoke yesterday aboutthe growing number of effective psoriasis treatments, which he also comparedto one another in terms of efficacy. He said the traditional model for psoriasistreatment, beginning with topical treatments that are replaced by strongertreatments as needed, should be abandoned. "It's just not working,"he said, citing a patient survey in which 78 percent of psoriasis patientsexpressed dissatisfaction with the treatments.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
JAK Inhibitors Show Comparable Safety to TNF Antagonists
2
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
3
Considering Biologics and Shared Decision-Making in Moderate to Severe Plaque Psoriasis: Part 2
4
"PDE4 Inhibitor-Responsive Dermatoses": A Modern Framework for Managing Inflammatory Skin Conditions
5














